ALABAMA
ALASKA
ARIZONA ARIZONA STEM CELL TREATMENT CENTER TEAM
Robert M Dryden, M.D., FACS, is Medical Director of the Arizona Stem Cell Treatment Center and Arizona Centre Plastic Surgery. Dr. Dryden completed his undergraduate training at the University of California at Davis, where he was Phi Beta Kappa (U. C. Berkeley chapter) and Phi Kappa Phi Honor Societies after only three years. He then matriculated at the University of California, School of Medicine where he was first in his class, elected to Alpha Omega Alpha Honor Society and a recipient of the prestigious Merck Award. After doing a rotating surgical and medical internship at the University Oregon in Portland, he completed a residency in ophthalmology at the University California in San Francisco. He was the first fellow in the prestigious fellowship in eye and facial plastic surgery under Drs. Crowell Beard and Marvin Quickert at the University of California. He subsequently spent two years at the National Institutes of Health as a member of the United States Public Health Service and consulted and performed cosmetic and reconstructive surgery at the National Naval Medical Center in Bethesda. Dr. Dryden has been practicing and teaching in Tucson and Phoenix, Arizona and at the University of Arizona Medical School since 1971. His practice includes eye and facial reconstructive plastic surgery, general cosmetic surgery, bio-identical hormone replacement and stem cell deployment as the Medical Director of the Arizona Center Stem Cell Treatment Center. Dr. Dryden is board certified in ophthalmology as well as board certified in General Cosmetic Surgery by the American Board of Cosmetic Surgery where he has been both a Trustee and Treasurer. Dr. Dryden was one of the initial founding members of the American Society of Ophthalmic Plastic and Reconstructive surgery and has served as President and Treasurer of the organization. He also served as a President of the American Society of Cosmetic Breast Surgery. He has published over 90 articles in peer-reviewed journals and book chapters in various textbooks. He is a Clinical Professor at the University of Arizona School of Medicine and Mentor of a fellowship in general cosmetic surgery and has taught doctors from around the world. Additionally, he has spoken and taught both nationally and internationally for 40 years. He is a pioneer in the use and development of the latest innovative surgical techniques in eyelid surgery, facial cosmetic surgery, liposuction surgery and breast surgery.
View my CV
PHOENIX STEM CELL TREATMENT CENTER TEAM
Steven M. Gitt, M.D., F.A.C.S. specializes in cosmetic surgery, offering the latest and most innovative techniques in: facial rejuvenation, breast augmentation, laser surgery, liposuction and body contouring and all facets of cosmetic surgery. His patients describe him as caring, compassionate, and understanding and as an excellent listener and communicator. As the founder and medical director of North Valley Plastic Surgery, established in 1993, Dr. Gitt graduated college with distinction from UCLA in 1982 and from medical school with distinction from Wayne State University in 1986. Dr. Gitt was elected to membership in the prestigious Alpha Omega Alpha (AOA) national medical honor society in 1985. Following completion of training in General Surgery at Good Samaritan Hospital in Phoenix, and Plastic Surgery training at the renowned University of Michigan medical center, Dr. Gitt obtained certifications from the American Board of Surgery and the American Board of Plastic Surgery. Dr. Gitt also holds the prestigious Certificate of Advanced Education in Cosmetic Surgery. He was the founder and original medical director of the Comprehensive Wound Healing Center at Paradise Valley Hospital in Phoenix, Arizona. Dr. Gitt is a board certified plastic surgeon. He is a member of the American Society of Plastic Surgeons. Always on the leading edge of technology, Dr. Gitt has offered endoscopic procedures such as brow and face lifting, abdominoplasty, and breast augmentation since 1994, carbon dioxide laser resurfacing since 1995, and Photoderm-Intense Pulsed Light Therapy (IPL) since 1996. He has also accumulated extraordinary experience in Fotofacial and Fotofacial-plusT IPL treatments
View my CV
Ryan B. Tsujimura, M.D. graduated magna cum laude from the University of Washington in Seattle with a B.S. in Biology. He remained in Seattle where he graduated at the top of his class and earned his Medical Degree from the University of Washington School of Medicine. Dr. Tsujimura initiated his postgraduate training at the Oregon Health Sciences University (University of Oregon) in Portland, Oregon where he did his internship in General Surgery. He then moved to Phoenix where he finished his residency in General Surgery. During this time he became Chief Resident of the Burn Unit and then Chief Resident of Surgery in his last year of training. He was given various awards during his training, but the most meaningful was the distinction made by the Chairman of Surgery/Program Director and Mentor: Ive been training surgeons for over a decade, youre the best surgeon Ive been fortunate enough to train. Certified by the American Board of Surgery, Dr. Tsujimura took an Attending Trauma Surgeon at Maricopa County Hospital. This gave him the opportunity to give back to the community and to teach future surgeons. To help influence the surgeons of tomorrow. During this time, he also entered practice and joined the staff of the Scottsdale Healthcare System performing general and vascular operations. Dedicated to patient care, he rapidly became the surgeon to turn to in a time of need. In the continued pursuit to perfect his skills, Dr. Tsujimura took an educational leave from a busy practice to obtain still further training at the Nationally Accredited by the American Board of Plastic Surgery and RRC (Residency Review Committee), Plastic/Reconstructive and Hand Surgery program at the University of Tennessee. While there, he published and lectured on various topics in Aesthetic and Reconstructive Surgery. He also became Administrative Chief Resident. Even during his training in plastic surgery, because of his surgical experience he was frequently called to the operating room by staff surgeons in times of crisis.
View my CV
Read more here:
Stem Cell Doctors, Physician Team, Our Doctors
- Japan Stem Cells Market to be at Forefront by 2028 - November 24th, 2022
- Mice Model Technologies Market Outlook, Competitive Landscape and Forecasts to 2031 - openPR - October 13th, 2022
- Cell & Tissue Preservation Market Size will Observe Lucrative Surge by the End 2031 - openPR - October 13th, 2022
- PRP and PRF in Cosmetics Market Growth Opportunities Analysis Report - openPR - October 13th, 2022
- Orthobiologics Market to Receive Overwhelming Hike in Revenues by 2031 - openPR - October 13th, 2022
- Stem Cells Market is Expected to Grow with High Probability Business Opportunity by 2028 - Digital Journal - October 4th, 2022
- External Beam Radiation Therapy Market: Growing Awareness about Early Detection and Diagnosis of various Cancer Types to Drive the Market - BioSpace - September 16th, 2022
- DiMethyl Sulfoxide (DMSO) Market to Touch US$ 838.6 Million in 2032 Owing to its Widespread Application in End-Use Industries & Anti-Inflammatory... - September 16th, 2022
- Virology Market Growth Prospects, Trends and Forecast up to 2030 - BioSpace - September 8th, 2022
- Cell Banking Outsourcing Market is Driven by Rising Number of Stem Cell Therapies across the Globe - BioSpace - September 8th, 2022
- Regenerative Therapies Market 2018 By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2026 - Digital Journal - August 22nd, 2022
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends, Competitive Landscape and Regional Insights to 2031 - BioSpace - August 14th, 2022
- Multiphoton Microscopy Market Insights, New Innovations, Research and Growth Factor till 2031 - BioSpace - August 14th, 2022
- Buffalo center fuels research that can save your life from heart disease and stroke - Buffalo News - August 5th, 2022
- Drug Discovery Services Market is Expected to Witness Significant Growth between 20212031 - BioSpace - July 27th, 2022
- Stem Cells Market to Expand at a CAGR of 10.4% from 2021 to 2028 Travel Adventure Cinema - Travel Adventure Cinema - July 27th, 2022
- Dental Membrane and Bone Graft Substitutes Market to Exceed Value of US$ 1,337 Mn by 2031 - PR Newswire UK - July 27th, 2022
- Lipid Disorder Treatment Market is Projected to Experience Promising Growth Opportunities in the Forthcoming Years - BioSpace - July 27th, 2022
- Immunoglobin Products Market to Witness Comprehensive Growth by 2031 - BioSpace - July 19th, 2022
- Antibody Therapy Market Propels at a Robust CAGR of 13.2% due to Rising Cancer and Other Chronic Disease Prevalence Future Market Insights, Inc. -... - July 19th, 2022
- Orthobiologics Market is Predicted to Expand at a CAGR of 4.7% during the Forecast Period, notes TMR Study - GlobeNewswire - July 11th, 2022
- Cell Line Development Market: Increase in Prevalence of Cancer and Other Chronic Diseases to Drive the Market - BioSpace - July 11th, 2022
- Transplant Diagnostic Market: Increase in Number of Cancer & Blood Disorder Patients to Drive the Market - BioSpace - July 11th, 2022
- Microscopy Devices Market Competitive Insights and Precise Outlook 2021-2028 Industrial IT - Industrial IT - June 4th, 2022
- Neoantigen Targeted Therapies Market Analysis and Opportunity Assessment up to 2027 - BioSpace - June 4th, 2022
- Why Eraser Enzymes Go Wrong and Lead to Cancer - SciTechDaily - December 10th, 2021
- MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of... - August 31st, 2021
- Incyte and MorphoSys Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults... - August 31st, 2021
- Rock snot discovered in another Pennsylvania waterway - pennlive.com - September 12th, 2020
- Bone Marrow and Stem Cell Transplants ChristianaCare - June 20th, 2020
- 'Billion Dollar Burger' Asks: What Is Meat? - Delaware First Media - June 17th, 2020
- Data from Incytes Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings - Yahoo Finance - May 20th, 2020
- Stem Cell therapy Middletown Delaware 19709 - February 10th, 2020
- First CAR-T cell cancer therapy patient in Delaware - Dover Post - February 10th, 2020
- Gore, Mayo Clinic team up to deliver breakthrough medical therapies - Plastics Today - December 17th, 2019
- Global Stem Cell Therapy Market 2019-2025 Analyzed by Business Growth, Development Factors, Applications, and Future Prospects - Technology Magazine - December 17th, 2019
- From inspiration to innovation | UDaily - UDaily - November 14th, 2019
- What Will Happen to Actinium Pharmaceuticals Inc (delaware (NYSEAMERICAN:ATNM) Next? The Stock Has Increase in Shorts - The Lamp News - October 26th, 2019
- Could Fate Therapeutics, Inc. (FATE) Recover After Forming a Bearish Head & Shoulders Pattern? - The Altcoin Mercury - September 25th, 2019
- Stem Cell therapy Lewes Delaware 19958 - September 14th, 2019
- Westfield High School Principal Derrick Nelson was 'gift ... - May 16th, 2019
- SignalRx - March 22nd, 2019
- Stem Cell therapy Newark Delaware 19725 - February 27th, 2019
- Stem Cell therapy Wilmington Delaware 19810 - February 27th, 2019
- Stem Cell Therapy | Regenerative Delaware - February 22nd, 2019
- Regenerative Cell Treatment &Therapy - Delaware ... - February 22nd, 2019
- Stem Cell Doctors Delaware, Stem cell injections, Stem ... - October 14th, 2018
- Regenerative Cell Therapy - Delaware Integrative Medicine - June 22nd, 2018
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - Delaware First Media - August 30th, 2017
- Detroit Lions' Paul Worrilow has beaten odds, inspires others to help - Detroit Free Press - July 2nd, 2017
- Lions LB Paul Worrilow Making A Difference On And Off The Field - FanRag Sports (blog) - July 2nd, 2017
- Lions LB Paul Worrilow gave stem cells to anonymous leukemia patient - Detroit Free Press - March 11th, 2017
- Delaware (Stem Cell) - what-when-how - November 3rd, 2016
- University of Delaware Chemical Engineering - October 31st, 2015
- Home | www.papoutsakis.org - October 4th, 2015
- Stem Cells - Eppendorf - October 2nd, 2015
- Efficient Differentiation of Mouse Embryonic Stem Cells ... - October 1st, 2015
- Alpine Rose Leaf Extract for Environmental Protection for ... - October 1st, 2015
- De-Differentiation of Somatic Cells to a Pluripotent State ... - June 29th, 2015
- DSU AgDiscovery 2015 - Investing in the Future of American ... - June 1st, 2015
- Stem-cell battles: Stem-cell research in the USA is facing ... - April 9th, 2015
- IPS Stem Cells: New Ethical Quandaries - Santa Clara ... - December 27th, 2014
- The California Cloning and Stem Cell Laws - December 27th, 2014
- Can a bodys own stem cells help heal a heart? - October 19th, 2014
- Delaware Stem Cell Treatment | Stem Cell Treatments - September 9th, 2014
- Core mechanism for root growth identified - August 25th, 2014
- Stem Cell Companies - A Comprehensive Overview - August 23rd, 2014
- California Stem Cell Report: California Stem Cell Agency ... - August 23rd, 2014
- Bone Marrow and Stem Cell Transplants - Christiana Care ... - August 22nd, 2014